Table 4.

Clinical improvement following treatment and application of other treatments during 6 months follow-up.

		Before matching			After matching
Variable	Time points	Group M (n = 60)	Group MS (n = 81)	P	Group M (n = 44)	Group MS (n = 44)	P
GIC	1 week after first intervention	1 (1–2)	1 (1–2)	.242	1 (1–2)	1 (1–1)	.398
	2 weeks after first intervention	1 (1–2)	1 (1–1)	.036	1 (1–2)	1 (1–1)	.456
	4 weeks after first intervention	1 (1–1)	1 (1–1)	.359	1 (1–1)	1 (1–1)	.977
	3-month follow-up	1 (1–1)	1 (1–1)	.331	1 (1–1)	1 (1–1)	.670
	6-month follow-up	1 (1–1)	1 (1–1)	.099	1 (1–1)	1 (1–1)	.317
GIC sore = 1, n (%)	1 week after first intervention	37 (61.7)	56 (69.1)	.355	32 (72.7)	35 (79.5)	.453
	2 weeks after first intervention	38 (63.3)	64 (79.0)	.040	32 (72.7)	35 (79.5)	.453
	4 weeks after first intervention	52 (86.7)	74 (91.4)	.372	41 (93.2)	41 (93.2)	.672
	3-month follow-up	52 (86.7)	74 (91.4)	.372	42 (95.5)	41 (93.2)	1.000
	6-month follow-up	58 (96.7)	81 (100)	.098	43 (97.7)	44 (100)	1.000
Other treatment during follow-up, n (%)		8 (13.3)	7 (8.6)	.372	2 (4.5)	3 (6.8)	1.000

Data are present as median (interquartile range) or number (%). Group M, MUA only; Group MS, MUA plus ISI.

GIC, the patients’ global impression of change, ISI = intra-articular steroid injection, MUA = manipulation under anesthesia.